Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
South Korean military plans to launch new division for future warfare
-
8
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Teen smoking, drinking decline, while mental health, dietary habits worsen
Caregen earns patent for peptide as treatment for obesity and diabetes
By 윤정현Published : Oct. 20, 2016 - 11:27
[DISCLOSURE] Caregen (214370) reported on Oct. 20 that it has obtained a patent for its new peptide as an effective treatment for obesity and diabetes.
The peptide causes blood sugar levels to remarkably drop and helps break down fat, which will also have significant potential for addressing diabetes.
New oral peptide drugs for treating diabetes are currently being evaluated in pre-clinical tests.
By Yun Jeong-hyeon (clareyun@heraldcorp.com)
The peptide causes blood sugar levels to remarkably drop and helps break down fat, which will also have significant potential for addressing diabetes.
New oral peptide drugs for treating diabetes are currently being evaluated in pre-clinical tests.
By Yun Jeong-hyeon (clareyun@heraldcorp.com)
